skip to Main Content
 

Data Deep Dive: CAR T-Cell Therapy for Large B-Cell Lymphoma

  • This page as PDF

Summary

Tune into our first episode in the Avalere Health Essential Voice series focused on disease education. In this segment, our experts discuss recent research that, using Medicare fee-for-service claims data, studied healthcare utilization, costs, outcomes, and other characteristics of patients who received CAR T-cell therapy for large B-cell lymphoma.

To listen to this video as a podcast or read the transcript, please visit our podcast page.

From beginning to end, our team synergy
produces measurable results. Let's work together.

Sign up to receive more insights about Real-World Data
Please enter your email address to be notified when new Real-World Data insights are published.

Back To Top